Published in J Clin Invest on July 01, 2006
Effect of Salicylate on Glucose Metabolism in Insulin Resistance States | NCT00258128
The Study of Inflammation on Blood Glucose Levels in Obese People | NCT00258115
Targeting Inflammation Using Salsalate for Type 2 Diabetes-stage II (TINSAL-T2D-II) | NCT00799643
Targeting Inflammation Using Salsalate in CardioVascular Disease (TINSAL-CVD) | NCT00624923
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D) (TINSAL-T2D) | NCT00392678
Cocarnit Effects on Macrophages Polarization (COMP-DM) | NCT03877523
Adiposity and Airway Inflammation in HIV-Associated Airway Disease (SHOP) | NCT02975258
Clinical Importance of Glucose Regulation in Relapsing MS | NCT03004079
Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest (2007) 20.19
Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature (2007) 11.59
A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab (2009) 11.46
CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med (2009) 11.28
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell (2010) 10.96
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med (2009) 9.71
Adipokines in inflammation and metabolic disease. Nat Rev Immunol (2011) 8.92
Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol (2010) 8.87
Type 2 diabetes as an inflammatory disease. Nat Rev Immunol (2011) 8.30
Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell (2009) 7.62
Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93
Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab (2008) 5.83
Lipid-induced insulin resistance: unravelling the mechanism. Lancet (2010) 4.88
Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol (2011) 4.68
A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37
Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest (2011) 4.17
Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J Clin Invest (2007) 3.88
Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes (2008) 3.80
The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A (2007) 3.76
Alternative macrophage activation and metabolism. Annu Rev Pathol (2011) 3.59
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med (2010) 3.56
Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab (2011) 3.38
Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest (2009) 3.37
Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes. Proc Natl Acad Sci U S A (2012) 3.27
Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet (2010) 3.24
Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB. Nat Med (2011) 3.15
Binge drinking induces whole-body insulin resistance by impairing hypothalamic insulin action. Sci Transl Med (2013) 3.07
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet (2008) 2.96
Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care (2007) 2.92
Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science (2013) 2.85
Diacylglycerol-mediated insulin resistance. Nat Med (2010) 2.82
Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol (2008) 2.82
Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity (2012) 2.80
The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol (2011) 2.77
Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol (2008) 2.75
Human genetics illuminates the paths to metabolic disease. Nature (2009) 2.74
SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol (2008) 2.73
Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem (2009) 2.69
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci (2008) 2.54
Cellular metabolic stress: considering how cells respond to nutrient excess. Mol Cell (2010) 2.50
"Control" laboratory rodents are metabolically morbid: why it matters. Proc Natl Acad Sci U S A (2010) 2.50
Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut (2011) 2.50
Metabolic syndrome: from epidemiology to systems biology. Nat Rev Genet (2008) 2.49
The metabolic syndrome: A high-risk state for cancer? Am J Pathol (2006) 2.46
Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes (2009) 2.42
IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity. Proc Natl Acad Sci U S A (2010) 2.37
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics (2009) 2.36
Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes (2009) 2.36
Control of macrophage activation and function by PPARs. Circ Res (2010) 2.34
The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol (2011) 2.33
Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes (2009) 2.27
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med (2011) 2.25
Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res (2007) 2.25
Mechanisms of macrophage activation in obesity-induced insulin resistance. Nat Clin Pract Endocrinol Metab (2008) 2.24
Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J Biol Chem (2010) 2.19
Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev Endocr Metab Disord (2010) 2.19
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. Nat Med (2013) 2.19
Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol (2012) 2.16
Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proc Natl Acad Sci U S A (2010) 2.10
Retracted Atorvastatin improves survival in septic rats: effect on tissue inflammatory pathway and on insulin signaling. PLoS One (2010) 2.08
The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev (2012) 2.01
Increased macrophage migration into adipose tissue in obese mice. Diabetes (2011) 1.98
Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol (2008) 1.97
Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice. Am J Physiol Endocrinol Metab (2008) 1.96
Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance. Diabetes (2012) 1.95
Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress. Mol Cell Biol (2010) 1.94
Leptin and the central nervous system control of glucose metabolism. Physiol Rev (2011) 1.94
A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response. Nat Med (2010) 1.93
A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity. PLoS One (2008) 1.90
Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome. Proc Natl Acad Sci U S A (2008) 1.89
Macrophage heterogeneity and tissue lipids. J Clin Invest (2007) 1.89
Effect of early particulate air pollution exposure on obesity in mice: role of p47phox. Arterioscler Thromb Vasc Biol (2010) 1.88
Protein kinase C-β contributes to impaired endothelial insulin signaling in humans with diabetes mellitus. Circulation (2012) 1.88
Xbp1s in Pomc neurons connects ER stress with energy balance and glucose homeostasis. Cell Metab (2014) 1.86
Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc Natl Acad Sci U S A (2008) 1.83
Retracted Impact of weight loss diet associated with flaxseed on inflammatory markers in men with cardiovascular risk factors: a clinical study. Nutr J (2015) 1.79
Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing fibroblast growth factor 21. Hepatology (2015) 1.78
Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. PLoS One (2011) 1.77
Minireview: Inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology (2010) 1.77
M2 Macrophage Polarization Mediates Anti-inflammatory Effects of Endothelial Nitric Oxide Signaling. Diabetes (2015) 1.77
Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis. Hepatology (2008) 1.76
Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol (2014) 1.76
Dietary leucine--an environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS One (2011) 1.74
BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. J Immunol (2013) 1.74
Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice. Hypertension (2010) 1.74
Retracted Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice. Circ Res (2008) 1.74
Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure. J Biol Chem (2009) 1.71
The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol (2009) 1.70
DGAT1-dependent triacylglycerol storage by macrophages protects mice from diet-induced insulin resistance and inflammation. J Clin Invest (2010) 1.70
Sleep loss and inflammation. Best Pract Res Clin Endocrinol Metab (2010) 1.69
NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol (2011) 1.69
Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Ann Intern Med (2013) 1.68
The major inflammatory mediator interleukin-6 and obesity. Inflamm Res (2009) 1.67
Sirtuin 1 in lipid metabolism and obesity. Ann Med (2011) 1.65
Long-term exposure to ambient fine particulate pollution induces insulin resistance and mitochondrial alteration in adipose tissue. Toxicol Sci (2011) 1.65
Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance. Cell Metab (2012) 1.64
Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes (2012) 1.62
Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne) (2013) 1.62
Development of insulin resistance in mice lacking PGC-1α in adipose tissues. Proc Natl Acad Sci U S A (2012) 1.61
Insulin resistance and pancreatic beta cell failure. J Clin Invest (2006) 1.60
Pathogen recognition and innate immunity. Cell (2006) 44.14
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Positional cloning of the mouse obese gene and its human homologue. Nature (1994) 38.85
Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (1993) 25.54
Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science (2004) 19.08
A central role for JNK in obesity and insulin resistance. Nature (2002) 17.27
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85
The hormone resistin links obesity to diabetes. Nature (2001) 15.49
Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest (2004) 13.42
IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med (2005) 12.07
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science (2001) 11.56
Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med (2005) 10.88
CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest (2005) 10.44
A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem (1995) 9.72
Thiazolidinediones. N Engl J Med (2004) 9.42
Inhibition of NF-kappa B by sodium salicylate and aspirin. Science (1994) 7.60
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47
The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem (2000) 7.41
Retracted Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science (2004) 7.21
Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes (2002) 7.17
Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes (1999) 7.14
Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab (1998) 7.05
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature (2005) 6.83
The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature (1998) 6.69
IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell (2004) 6.25
Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A (2003) 6.06
Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem (2001) 5.61
Is type II diabetes mellitus a disease of the innate immune system? Diabetologia (1998) 5.43
Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes (2003) 5.43
Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem (2001) 5.12
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest (2002) 4.96
Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl) (2005) 4.96
Prevention of fat-induced insulin resistance by salicylate. J Clin Invest (2001) 4.74
Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest (1983) 4.70
Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes (1994) 4.66
Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes (2002) 4.58
Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res (2005) 4.24
Current concepts of the pathogenesis of the acute coronary syndromes. Circulation (2001) 4.23
Reversal of obesity by targeted ablation of adipose tissue. Nat Med (2004) 4.23
Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet (1999) 4.07
The liver as an immunological organ. Hepatology (2006) 3.86
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes (2002) 3.59
The selectins: vascular adhesion molecules. FASEB J (1995) 3.45
Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology (2005) 3.35
The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem (2004) 3.31
Combinatorial roles of nuclear receptors in inflammation and immunity. Nat Rev Immunol (2006) 3.20
Aspirin and diabetes mellitus. Br Med J (1957) 3.09
Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med (1996) 3.02
Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet (1994) 2.96
Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem (1993) 2.94
Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord (2003) 2.89
Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol (2006) 2.80
An immune origin of type 2 diabetes? Diabetologia (2005) 2.76
Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med (2002) 2.70
A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation (1997) 2.59
The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes (2001) 2.47
Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes (2005) 2.46
Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes (2006) 2.40
Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. J Immunol (1989) 2.39
High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes (2002) 2.36
A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes (2005) 2.30
Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol (1990) 2.22
Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. Annu Rev Cell Dev Biol (2004) 2.21
Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation (1997) 2.12
Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J Immunol (1996) 2.11
Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology (2000) 2.10
Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes. J Vasc Res (2005) 2.06
Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci STKE (2005) 2.04
Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302. J Biol Chem (2004) 1.97
CD40 signaling and plaque instability. Circ Res (2001) 1.97
On the Treatment of Glycosuria and Diabetes Mellitus with Sodium Salicylate. Br Med J (1901) 1.92
Cellularity of adipose depots in six strains of genetically obese mice. J Lipid Res (1972) 1.84
Salicylates as hypoglycemic agents. Diabetes Care (1983) 1.83
Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance. J Clin Invest (2004) 1.79
Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis (1996) 1.74
Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab (2002) 1.73
Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes (2004) 1.56
Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping. J Pathol (2006) 1.46
Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. Am J Epidemiol (2002) 1.32
Invited comment on W. Ebstein: On the therapy of diabetes mellitus, in particular on the application of sodium salicylate. J Mol Med (Berl) (2002) 1.31
Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine (1994) 1.30
Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age. J Clin Endocrinol Metab (1992) 1.29
Reappraisal of the hypoglycemic action of acetylsalicylate. Metabolism (1959) 1.28
FIBRINOLYSIS IN OBESITY. Lancet (1964) 1.23
Reduction of blood fibrinolytic activity in diabetes mellitus by insulin. Lancet (1959) 1.20
Fibrinolysis and body bulid. Interrelationships between blood fibrinolysis, body composition and parameters of lipid and carbohydrate metabolism. J Atheroscler Res (1968) 1.20
The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond. Trends Cardiovasc Med (2005) 1.16
Mechanism of the anti-inflammatory effect of thiazolidinediones: relationship with the glucocorticoid pathway. Mol Pharmacol (2005) 1.11
White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men. Diabetologia (2002) 1.09
Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trial. Arterioscler Thromb Vasc Biol (2006) 1.07
The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects. Metabolism (1981) 0.99
Identification and importance of brown adipose tissue in adult humans. N Engl J Med (2009) 20.57
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A (2003) 17.10
Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med (2005) 10.88
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med (2009) 9.71
IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell (2004) 6.25
PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature (2012) 4.31
Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) (2009) 3.15
Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care (2007) 2.92
Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA (2004) 2.70
Association between fine particulate matter and diabetes prevalence in the U.S. Diabetes Care (2010) 2.60
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci (2008) 2.54
Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res (2002) 2.37
Statins and risk of new-onset diabetes mellitus. Circulation (2012) 2.27
Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol (2012) 2.16
Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis. Cell Metab (2011) 2.08
Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records. Diabetes Care (2009) 2.00
The cellular fate of glucose and its relevance in type 2 diabetes. Endocr Rev (2004) 1.98
Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302. J Biol Chem (2004) 1.97
Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging. JACC Cardiovasc Imaging (2010) 1.81
Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance. Diabetes (2006) 1.71
Obesity and type 2 diabetes: what can be unified and what needs to be individualized? J Clin Endocrinol Metab (2011) 1.63
Inflammation and adipose tissue macrophages in lipodystrophic mice. Proc Natl Acad Sci U S A (2009) 1.61
Thyroid hormone-related regulation of gene expression in human fatty liver. J Clin Endocrinol Metab (2009) 1.44
Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. J Biol Chem (2003) 1.35
Human insulin analog--induced lipoatrophy. Diabetes Care (2007) 1.34
Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance. J Clin Invest (2011) 1.33
Obesity and type 2 diabetes: what can be unified and what needs to be individualized? Diabetes Care (2011) 1.31
The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes (2010) 1.30
Getting away from glucose: fanning the flames of obesity-induced inflammation. Nat Med (2009) 1.28
Insulin enhances glucose-stimulated insulin secretion in healthy humans. Proc Natl Acad Sci U S A (2010) 1.25
Kinase activation through dimerization by human SH2-B. Mol Cell Biol (2005) 1.22
Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol (2003) 1.20
Plasma ceramides are elevated in female children and adolescents with type 2 diabetes. J Pediatr Endocrinol Metab (2013) 1.19
PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans. J Clin Invest (2011) 1.15
The great debate: medicine or surgery: what is best for the patient with type 2 diabetes? Diabetes Care (2011) 1.06
Peptide YY levels are elevated after gastric bypass surgery. Obesity (Silver Spring) (2006) 1.05
Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans. Diabetes (2012) 1.04
Insulin response to oral stimuli and glucose effectiveness increased in neuroglycopenia following gastric bypass. Obesity (Silver Spring) (2015) 1.03
Effect of ranolazine on A1C and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndrome. Diabetes Care (2010) 0.95
Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study. Acta Diabetol (2014) 0.94
Confronting the type 2 diabetes epidemic: the emerging role of incretin-based therapies. Am J Med (2010) 0.91
Protective unfolded protein response in human pancreatic beta cells transplanted into mice. PLoS One (2010) 0.90
Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin. J Clin Endocrinol Metab (2014) 0.90
Glucagon treatment for post-gastric bypass hypoglycemia. Obesity (Silver Spring) (2010) 0.90
Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acids. J Clin Endocrinol Metab (2011) 0.87
Inhibition of protein kinase Cbeta does not improve endothelial function in type 2 diabetes. J Clin Endocrinol Metab (2010) 0.86
Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus. Am J Cardiol (2006) 0.85
Continuous glucose monitoring for evaluation of glycemic excursions after gastric bypass. J Obes (2011) 0.85
Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes. Invest Ophthalmol Vis Sci (2012) 0.85
Endothelial function varies according to insulin resistance disease type. Diabetes Care (2007) 0.84
Cardiovascular safety and diabetes drug development. Lancet (2011) 0.84
Acute insulin secretion as a predictor of weight gain in healthy humans. Obesity (Silver Spring) (2006) 0.84
The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes. Diabetes Care (2013) 0.82
Bariatric surgery for diabetes management. Curr Opin Endocrinol Diabetes Obes (2009) 0.81
Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk. J Clin Invest (2017) 0.81
Profilin-1 haploinsufficiency protects against obesity-associated glucose intolerance and preserves adipose tissue immune homeostasis. Diabetes (2013) 0.80
Changing prescribing patterns of type 2 diabetes medications from 2002-2010: an electronic health record-based evaluation. J Diabetes Sci Technol (2013) 0.80
Metabolic surgery for type 2 diabetes: efficacy and risks. Curr Opin Endocrinol Diabetes Obes (2013) 0.80
The rough road for rosiglitazone. Curr Opin Endocrinol Diabetes Obes (2008) 0.79
Cardiovascular risk assessment in the development of new drugs for obesity. JAMA (2012) 0.79
Life and death in Denmark: lessons about diabetes and coronary heart disease. Circulation (2008) 0.78
Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients. Metallomics (2013) 0.78
Cromolyn sodium for insulin-induced lipoatrophy: old drug, new use. Diabetes Care (2013) 0.77
What cost weight loss? Circulation (2012) 0.77
Atazanavir improves cardiometabolic measures but not vascular function in patients with long-standing type 1 diabetes mellitus. Acta Diabetol (2015) 0.76
Response to letter regarding article, ''Statins and risk of new-onset diabetes mellitus''. Circulation (2013) 0.75
Lactation after normal pregnancy is not associated with blood glucose fluctuations. Diabetes Care (2007) 0.75
Beta-cell insulin secretory response to oral hypoglycemic agents is blunted in humans in vivo during moderate hypoglycemia. J Clin Endocrinol Metab (2004) 0.75
Diabetes: advances and controversies. Clin Chem (2010) 0.75
IMPROVEMENTS IN METABOLIC CONTROL IN ADULTS WITH TYPE 2 DIABETES FOLLOWING REFERRAL TO A DIABETES CENTER, 2005-2010. Endocr Pract (2016) 0.75
Changing horizons: approaches to diabetes care, current and future. Curr Opin Endocrinol Diabetes Obes (2007) 0.75